Tuberculous empyema: Risk factors and prognosis

Soumaya Ben Saad (Bizerte, Tunisia), Bouthaina Melki, Soumaya Ben Saad, Hahaoua Daghfous, Mouna Ben Khlifa, Fatma Tritar

Source: International Congress 2015 – Case series and clinical conundrums in TB
Session: Case series and clinical conundrums in TB
Session type: Thematic Poster Session
Number: 2760
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Abstract

BACKGROUND: Empyema is a well known complication of pulmonary tuberculosis (TB), particularly in patients with advanced TB.AIM OF STUDY: To identify risk factors and prognosis of tuberculous empyema.METHODS: Retrospective comparative study of 210 patients followed up between 2010 and 2014 for pulmonary TB. We defined 2 groups: G1 (39 TB patients with empyema) and G2: (176 TB patients without empyema).RESULTS: Of the 39 patients in G1, 30 (78%) were male. The mean age in G1 was 37 years (12-74 years). Empyema was not significantly associated with sex, age, vaccination or medical history of TB. It was significantly more common in patients from rural area, who have served time with smoking history, drug and alcohol use. Mean time of general symptoms was about 81 days in G1 and there were no differences compared to G2. Cachexia was noted in 32% of our patients and it was statistically more common. In terms of radiological manifestations, 56% of patients with empyema had cavitary lesions and pulmonary infiltration. These lesions were not significantly more frequent. All patients had pleural drainage, respiratory physiotherapy and antitubercular drugs. Five patients in G1 had surgical treatment. At the end of treatment, extended radiological images and pulmonary sequelae were statistically more common in G1.CONCLUSIONS: Tuberculous empyema has as risk factors: smoking history, drug and alcohol use and living in rural area. Its early management is necessary to reduce pulmonary sequelae.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Soumaya Ben Saad (Bizerte, Tunisia), Bouthaina Melki, Soumaya Ben Saad, Hahaoua Daghfous, Mouna Ben Khlifa, Fatma Tritar. Tuberculous empyema: Risk factors and prognosis. Eur Respir J 2015; 46: Suppl. 59, 2760

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Risk factors for disseminated tuberculosis
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014

Predictive factors of recurrent pulmonary tuberculosis
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 3
Year: 2014


Tuberculosis recurrence
Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children
Year: 2015


Risk factors associated to surgical treatment of parapneumonic effusion and empyema
Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections
Year: 2013


Tuberculous pleuritis – Single centre experience
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II
Year: 2013

Management of pulmonary tuberculosis sequelae
Source: International Congress 2015 – Case series and clinical conundrums in TB
Year: 2015


Oesophageal perforation secondary to tuberculous lymphadenitis: Experience of a tertiary centre
Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe
Year: 2016

Risk factors of severe clinical forms of tuberculosis
Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe
Year: 2016


Fibrosing mediastinitis and tuberculosis: A Brazilian case report
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014

Risk factors for tuberculosis relapse in Polish patients
Source: Annual Congress 2013 –Drug-resistant tuberculosis
Year: 2013

Perinatal tuberculosis: A forgotten disease?
Source: International Congress 2016 – Paediatric respiratory infections
Year: 2016


Tuberculosis and venous thromboembolism:Clinical features and outcomes
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Year: 2014


Risk factors for fatal outcome in aspiration pneumonia cases with postural drainage
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016

Outcomes of cervical mediastinoscopy for undiagnosed lymphadenopathy: TB or not TB?
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013


Statin use and the risk of tuberculosis: Data from 305,142 patients
Source: International Congress 2016 – New insights into aspects of tuberculosis epidemiology
Year: 2016


Granulomatous lymphadenitis: Experience of a portuguese oncologic institute
Source: International Congress 2015 – Acute and chronic lung diseases: good clinical practice
Year: 2015


Socioeconomical impact of surgical treatment of empyema in adults
Source: Annual Congress 2013 –Chest wall and pleura
Year: 2013

Impact of diabetes on the presenting features of tuberculosis patients
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2
Year: 2014


Alternative surgical treatment for tuberculous cavern grafted by micosis
Source: Annual Congress 2013 –Surgery for pleuropulmonary and mediastinal benign diseases
Year: 2013


Features of pulmonary tuberculosis in migrants
Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children
Year: 2015